A Study to Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohn's Disease
Clinical trial NCT04643483 · WITHDRAWN
Trial details
- NCT number
- NCT04643483
- Sponsor
- UCB Biopharma SRL
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2023-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.